Amneal Pharmaceuticals Inc. logo

Amneal Pharmaceuticals Inc.

AMRX | NASDAQ
Chart Builder DCF Calculator
$19.31
-$0.85 (-4.22%)
Sep 22, 2026, 12:44 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
310.87M 110.55M 91.54M 25.98M 247.79M 341.38M
Short-Term Investments
n/a 1.87M 2.2M 1.82M n/a 1.7M
Long-Term Investments
7.82M 35.92M 37.09M 85.59M n/a n/a
Other Long-Term Assets
49.98M 24.21M 18.43M 17.63M 20.61M 22.34M
Receivables
939.87M 775.73M 645.66M 741.79M 694.74M 639M
Inventory
606.3M 612.45M 581.38M 530.74M 489.39M 490.65M
Other Current Assets
4.44M 40.7M 7.57M 64.37M 41.95M 40.96M
Total Current Assets
1.91B 1.59B 1.38B 1.41B 1.52B 1.55B
Property-Plant & Equipment
550.33M 523.69M 550.14M 589.36M 639M 604.71M
Goodwill & Intangibles
1.16B 1.33B 1.49B 1.69B 1.76B 1.83B
Total Long-Term Assets
1.77B 1.91B 2.09B 2.39B 2.42B 2.45B
Total Assets
3.68B 3.5B 3.47B 3.8B 3.94B 4.01B
Account Payables
254.67M 259.84M 143.57M 166.84M 131.08M 154.14M
Deferred Revenue
n/a n/a 398.41M n/a n/a n/a
Short-Term Debt
21.58M 324.21M 213.13M 89.96M 30.61M 45.23M
Other Current Liabilities
525.5M 222.36M 3.91M 263.11M 120.1M 207.31M
Total Current Liabilities
881.63M 1.13B 846.6M 752.8M 677.24M 676.9M
Long-Term Debt
2.61B 2.16B 2.43B 2.63B 2.72B 2.83B
Other Long-Term Liabilities
75.79M 163.33M 41.77M 97.12M 65.43M 31.05M
Total Long-Term Liabilities
2.79B 2.42B 2.56B 2.84B 2.9B 2.97B
Total Liabilities
3.67B 3.55B 3.41B 3.59B 3.57B 3.65B
Total Debt
2.74B 2.59B 2.75B 2.85B 2.88B 3B
Book Value
5.96M -44.54M 61.3M 208.93M 366.97M 356.74M
Book Value Per Share
0.02 -0.14 0.35 1.38 2.42 2.40
Common Stock
3.15M 3.1M 3.07M 3.04M 3.01M 3M
Retained Earnings
-535.01M -607.06M -490.18M -406.18M -276.2M -286.82M
Comprehensive Income
-110.73M -65.51M -32.35M 9.94M -24.83M -41.32M
Shareholders Equity
-70.79M -109.27M 19.78M 298.42M 360.34M 303.27M
Total Investments
7.82M 37.79M 39.29M 87.41M n/a 1.7M

© 2026 bestshares.com. All rights reserved.